How should I evaluate and manage a 22-year-old patient with an absolute eosinophil count of 614 cells/µL?

Evaluation and Management of a 22-Year-Old with Absolute Eosinophil Count of 614 cells/µL

This is mild eosinophilia (0.614 × 10⁹/L) that requires a focused history and targeted investigation, but does not warrant urgent intervention or hematology referral at this level. 1

Initial Classification

Your patient has mild eosinophilia (defined as AEC > 0.5 × 10⁹/L but < 1.5 × 10⁹/L). This level is below the threshold for hypereosinophilia (≥1.5 × 10⁹/L) and well below levels that typically indicate serious pathology 1, 2.

Key context: Recent data shows that AEC >30,000/µL in adults is rarely due to parasitic infection and should prompt urgent evaluation for malignancy, while most parasitic infections cause mild-moderate eosinophilia 3. Your patient's level of 614 cells/µL falls squarely in the range where common causes predominate.

Critical History Elements to Obtain

Focus your history on these specific areas:

Travel and Migration History:

• Any travel to or residence in helminth-endemic regions (sub-Saharan Africa, Southeast Asia, South America)
• Freshwater exposure in endemic areas (schistosomiasis risk)
• Consumption of raw/undercooked freshwater fish, crab, or wild game
• Time since last travel (incubation periods vary: 2-8 weeks for schistosomiasis, 65-90 days for paragonimiasis) 1

Medication History:

• All current and recently discontinued medications (drug-induced eosinophilia is common) 1

Atopic Disease:

• Asthma, eczema, allergic rhinitis (most common non-infectious cause in low-endemic countries) 1

Symptom Screen for Organ Involvement:

• Respiratory: cough, wheeze, dyspnea, hemoptysis
• Gastrointestinal: abdominal pain, diarrhea, weight loss, blood in stool
• Dermatologic: rash, pruritus, skin lesions
• Neurologic: headache, focal deficits, seizures
• Cardiac: chest pain, palpitations (critical for hypereosinophilic syndrome, though unlikely at this AEC) 1

Diagnostic Approach

If Asymptomatic with No Travel History:

Most likely causes are atopic disease or medications. Consider:

• Review for asthma/atopy history
• Medication review and possible trial of discontinuation if suspect drug cause
• Repeat CBC in 4-6 weeks to assess persistence
• No immediate parasitic workup needed if truly no travel/migration history 1

If Travel/Migration History to Endemic Areas:

Implement first-line parasitic screening per 2025 UK guidelines 1:

1. Concentrated stool microscopy (3 samples on separate days)
2. Strongyloides serology (critical - can cause fatal hyperinfection if immunosuppressed later)
3. Schistosoma serology (if freshwater exposure in endemic areas)
4. Filarial serology (ONLY if travel to/residence in West Africa - no longer routine first-line) 1
5. HIV testing per BHIVA guidelines (helminth co-infection more likely cause if positive) 1

Important caveat: Concentrated stool microscopy has lower sensitivity for Strongyloides compared to serology, and helminth infections are frequently asymptomatic 1. Serology may remain positive for years after successful treatment, so cannot assess treatment response 1.

Treatment Recommendations

For Asymptomatic Eosinophilia with Travel History (Age >24 months):

Consider empirical treatment with albendazole 400 mg single dose PLUS ivermectin 200 μg/kg single dose to cover possible prepatent or undetected geohelminth infections (ascariasis/hookworm/strongyloidiasis) even if stool microscopy is negative 1.

CRITICAL WARNING: Must exclude Loa loa before giving ivermectin in patients who traveled to endemic regions (West/Central Africa). Ivermectin can cause fatal encephalopathy in patients with high Loa loa microfilaremia (>1000/mL) 1.

For schistosomiasis: If treating empirically or confirmed, repeat treatment at 8 weeks because eggs and immature schistosomulae are relatively resistant to initial treatment 1.

For Symptomatic Presentations:

Treatment depends on specific pathogen identified - see guideline for detailed pathogen-specific regimens 1.

When to Refer or Escalate

Do NOT refer to hematology at this AEC level unless:

• Eosinophilia persists ≥1.5 × 10⁹/L for >3 months after excluding/treating infectious causes 1
• Any evidence of end-organ damage (cardiac, pulmonary, neurologic, dermatologic) - requires urgent assessment 1

Recent evidence shows: An AEC threshold of 1.5 × 10⁹/L has 97% sensitivity for clinically meaningful eosinophilia requiring hematology evaluation 4. Your patient at 0.614 × 10⁹/L is well below this.

Follow-Up

• Repeat CBC in 4-6 weeks if asymptomatic and no treatment given
• If empirical treatment given, repeat CBC at 8-12 weeks to confirm resolution
• Persistent eosinophilia >3 months warrants expanded workup for non-infectious causes 1

Bottom line: At 614 cells/µL in a 22-year-old, focus on travel history and atopic disease. If travel history positive, do parasitic screening and consider empirical treatment. This level does not require urgent intervention or specialist referral unless symptomatic with organ involvement.